Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dyspepsia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dyspepsia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boeckxstaens, GE; Booij, J; Braak, B; Klooker, TK; van den Wijngaard, RM1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dyspepsia

ArticleYear
The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Aged; alpha-Methyltyrosine; Benzamides; Case-Control Studies; Dopamine; Drinking; Dyspepsia; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Postprandial Period; Prolactin; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Young Adult

2012